Headway made towards biosignatures for incipient tuberculosis

TJ Scriba, SC Mendelsohn - The Lancet Respiratory Medicine, 2020 - thelancet.com
included patients who discontinued clofazimine did so because of hyperpigmentation. 7
More patients probably continued treatment despite hyperpigmentation, which attracts social …
被引用次数：5 相关文章
[HTML] nih.gov

[HTML][HTML] Headway made towards biosignatures for incipient tuberculosis

TJ Scriba, SC Mendelsohn - The Lancet. Respiratory medicine, 2020 - ncbi.nlm.nih.gov
Identification of individuals with tuberculosis for antibiotic treatment is a major component of
the of WHO's End TB Strategy. 1 Diagnostic tests for tuberculosis rely on detection of …

Headway made towards biosignatures for incipient tuberculosis

TJ Scriba, SC Mendelsohn - The Lancet. Respiratory …, 2020 - pubmed.ncbi.nlm.nih.gov
Headway made towards biosignatures for incipient tuberculosis Headway made towards
biosignatures for incipient tuberculosis Lancet Respir Med. 2020 Apr;8(4):328-330. doi …

Headway made towards biosignatures for incipient tuberculosis.

TJ Scriba, SC Mendelsohn - The Lancet. Respiratory Medicine, 2020 - europepmc.org
Identification of individuals with tuberculosis for antibiotic treatment is a major component of
the of WHO's End TB Strategy. 1 Diagnostic tests for tuberculosis rely on detection of …